We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · December 28, 2020

Novel OPV2 Vaccines Compared With Monovalent OPV2 Vaccine

The Lancet


Additional Info

The Lancet
Safety and Immunogenicity of Two Novel Type 2 Oral Poliovirus Vaccine Candidates Compared With a Monovalent Type 2 Oral Poliovirus Vaccine in Healthy Adults: Two Clinical Trials
Lancet 2020 Dec 09;[EPub Ahead of Print], I De Coster, I Leroux-Roels, AS Bandyopadhyay, C Gast, K Withanage, K Steenackers, P De Smedt, A Aerssens, G Leroux-Roels, MS Oberste, JL Konopka-Anstadt, WC Weldon, A Fix, J Konz, R Wahid, J Modlin, R Clemens, SA Costa Clemens, NS Bachtiar, P Van Damme

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading